Condition: Asthma · Inflammation · Sponsor: St. Olavs Hospital
The overall objective of the study is to determine the efficacy of corticosteroids in preventing recurrent wheezing and asthma in high-risk, first-time severe wheezing children with rhinovirus infection, stratified by rhinovirus genome load. The secondary objectives are to determine duration and severity of each acute episode with acute expiratory breathing difficulty, the number of episodes with acute expiratory breathing difficulty, degree of pulmonary hyperreactivity and quality of life within 24 months after study entry.
This description comes directly from the study's public registry record.
Henrik Døllner, md phd · 0047 73559531 · henrik.dollner@ntnu.no
Always discuss trial participation with your own doctor first.
| Turku University Hospital | Turku, Finland | Recruiting |
| Haukeland University Hospital | Bergen, Norway | Recruiting |
| Akershus University Hospital | Oslo, Norway | Recruiting |
| Ullevål University Hospital | Oslo, Norway | Recruiting |
| Stavanger University Hospital | Stavanger, Norway | Recruiting |
| University Hospital of North Norway | Tromsø, Norway | Recruiting |
| St Olavs Hospital | Trondheim, Norway | Recruiting |
| Karolinska Universitetssjukhuset | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03889743